KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
The Private Equity Tax Express specifically focuses on key China tax issues facing private equity transactions. This publication is issued on an ad hoc basis.
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.